Chemo Pharma Laboratories Limited

BSE:506365 Stock Report

Market Cap: ₹126.0m

Chemo Pharma Laboratories Balance Sheet Health

Financial Health criteria checks 6/6

Chemo Pharma Laboratories has a total shareholder equity of ₹124.2M and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹124.3M and ₹143.0K respectively. Chemo Pharma Laboratories's EBIT is ₹13.8M making its interest coverage ratio 127.5. It has cash and short-term investments of ₹59.9M.

Key information

0%

Debt to equity ratio

₹0

Debt

Interest coverage ratio127.5x
Cash₹59.86m
Equity₹124.18m
Total liabilities₹143.00k
Total assets₹124.32m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 506365's short term assets (₹63.6M) exceed its short term liabilities (₹143.0K).

Long Term Liabilities: 506365 has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: 506365 is debt free.

Reducing Debt: 506365 had no debt 5 years ago.

Debt Coverage: 506365 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 506365 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.